HL7 FHIR Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment 2)
This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.2.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
BC DCISNuclearGradeVS ValueSet
The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. In breast cancer, nuclear grade is typically evaluated for ductal carcinoma in situ (DCIS) only.
| Defining URL: | http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-DCISNuclearGradeVS |
| Version: | 0.2.0 |
| Name: | DCISNuclearGradeVS |
| Definition: | The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. In breast cancer, nuclear grade is typically evaluated for ductal carcinoma in situ (DCIS) only. |
| Publisher: | The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC) |
| Source Resource: | XML / JSON / Turtle |
This value set contains 4 concepts
All codes from system http://snomed.info/sct
| Code | Display | Definition |
| 369781009 | Ductal carcinoma in situ nuclear pleomorphism, grade 1: monotonous nuclei, 1.5 - 2.0 red blood cells diameters, with finely dispersed chromatin and only occasional nucleoli (finding) | |
| 369782002 | Ductal carcinoma in situ nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3 (finding) | |
| 369783007 | Ductal carcinoma in situ nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 red blood cells diameters, with coarse chromatin and multiple nucleoli (finding) | |
| 384741006 | Grade cannot be determined (finding) |